BNO
Click for more information
0.00% 1.0¢ bionomics limited

Ann: Phase 2 PTSD Clinical Trial Fully Recruited, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. joohnno
    2,410 Posts.
    lightbulb Created with Sketch. 629
    clock Created with Sketch.
    11/04/18
    10:58
    Post #: 32370988
    Does anyone know the period of treatment for the trial? As this should give a fairly clear indication of when results might be available. I.e. full recruitment date + treatment period + results analysis.
    BNO Price at posting: 56.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS FDA clearance secured for AI-enabled EchoSolv AS – ready for rapid U.S. market launch
right-arrow Created with Sketch.
NEWS Exceptional niobium intercepts confirmed at Stinger Discovery – dive into the latest assays
right-arrow Created with Sketch.
NEWS Most viewed thread today: Exceptional Niobium Intercepts at the Stinger Discovery
right-arrow Created with Sketch.
LU7 The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
right-arrow Created with Sketch.
NEWS Gold nuggets unearthed at Comet Well ahead of drilling! Discoveries continue as exploration ramps up
right-arrow Created with Sketch.
NEWS High-grade rare earth and titanium discoveries confirmed from maiden RC drilling at Mata da Corda, highlighting significant exploration potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.